CMBH Clinical Research
Scientific leadership, sponsor development, research strategy, L1 investigator relationships, and CMBH Research Intelligence, which is in development.
Advancing Scientific Excellence. Expanding Research Capacity.
Leading Investigators. More Patients. One Connected Network.
CMBH connects distinguished investigators, developing research leaders, independent physician sites, academic collaborators and specialized CRO expertise to help sponsors identify research opportunities, expand access to qualified patient populations and execute rigorous multi-site clinical studies.
These are complementary functions and external relationships, not separate subsidiaries. SerenaGroup and academic collaborators are independent of CMBH. Sponsors and each site's investigator keep their own legal and regulatory duties.
Investigator-led, multi-site research with coordinated study management.
Learn moreA pathway from emerging research partner to distinguished investigator.
Learn moreJoin the research community, share your perspective, or learn about research.
Learn moreOne connected platform
These are functions and external relationships working together, not four operating companies. SerenaGroup and academic collaborators are independent of CMBH.
Scientific leadership, sponsor development, research strategy, L1 investigator relationships, and CMBH Research Intelligence, which is in development.
Physician-led development, qualification, activation support, and coordinated management of participating sites, primarily L2 and L3.
Independent strategic CRO and technical research partner, supporting methodology, regulatory, operations, statistics, and data functions as contracted.
Research question development, rigorous methodology, independent review, and responsible dissemination, when actual collaborators are engaged.
The network advantage
CMBH is building the infrastructure to expand established investigator-led research through additional qualified sites, support advancing physicians as they grow into research leaders, and help community practices connect patients with appropriate clinical studies. We expand investigators' reach. We do not replace them.
Help established principal investigators extend their programs across qualified participating sites and additional potentially eligible patient populations.
Mentorship, trial experience, scientific collaboration, and a competency-based pathway toward greater research leadership.
Share appropriately approved study information with patients, or pursue site qualification to take part in investigator-led research.
Reach relevant investigators, qualified sites, and potentially eligible patient populations, subject to feasibility and study-specific agreements.
Eligibility, enrollment, advancement, and study awards are never promised. L1 to L3 are CMBH program categories, not FDA designations.
CMBH Clinical Research is building a national investigator-led research network supported by specialized CRO expertise through its strategic relationship with SerenaGroup. CMBH brings the investigators, sponsor relationships and research opportunities, and Unity Site Network develops and coordinates participating sites. SerenaGroup contributes established clinical research methodology and technical expertise in areas such as protocol design, statistics, regulatory support, data operations and quality processes, subject to each study's agreements. Together, the model combines investigator credibility, patient access, and research execution expertise.
CMBH is an independent platform and may also collaborate with other CROs, institutions and technical providers on a study-specific basis. No other provider is named or implied here.
Why CMBH
We do not replace established investigators. We expand their reach, and we bring community physicians into research through a clear, documented pathway.
Experienced investigators guide the science, mentor others, and extend their reach through the network.
Access to qualified community physician sites and the patient populations they serve, confirmed for each study.
Coordination with specialist CRO partners who perform technical services as specifically contracted.
A pathway from emerging research partner to distinguished investigator, based on documented competence.
CMBH Research Intelligence, a platform in development, is intended to support human scientific review of research opportunities.
The sponsor keeps oversight. Each site keeps its own qualified investigator. The technical partner performs the duties delegated to it.
Better Science. Broader Access. Stronger Evidence.
Initial therapeutic focus
Aesthetic and therapeutic toxin studies.
Supported by SerenaGroup's wound-care research background.
Neurology studies, including migraine.
Expanding as qualified investigators join
Added with psychiatric investigators, across scientifically justified approaches.
Added with qualified investigators and sites.
Autism, ADHD and neurodevelopmental research across devices, digital therapeutics, behavioral interventions, observational studies, and pharmaceuticals, as justified by the science.
Patient & caregiver voice
Share perspectives on unmet medical needs, treatment experiences and barriers to clinical trial participation, or separately express interest in hearing about future research opportunities. Patient perspectives may help inform research questions and investigator and sponsor discussions.
CMBH is developing a permission-based community for people who want to learn about research, express interest in future studies, and contribute perspectives on unmet medical needs. Participation is independent of any particular clinic, sponsor, or study.